Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | 1₹1Accepted-AOC MODULE NO 407 AND 408 4TH FLOOR TARAMANI CHENNAI TAMIL NADU 600113 | CHENNAI | TAMIL NADU | 600113 | ₹1 | 1 | Accepted-AOC L1 |
| 2 | 1₹1Accepted-AOC 17TH FLOOR BUILDING 5 TOWER C DLF CYBER CITY PHASE III GURGAON HARYANA 122002 | GURUGRAM | HARYANA | 122002 | ₹1 | 1 | Accepted-AOC L1 |
| 3 | 1₹1Accepted-AOC K 796 ASHIYANA LUCKNOW UTTAR PRADESH 226012 | LUCKNOW | UTTAR PRADESH | 226012 | ₹1 | 1 | Accepted-AOC L1 |
| 4 | 1₹1Accepted-AOC MUMBAI | ₹1 | 1 | Accepted-AOC L1 |
| 5 | 2₹2+₹1 (100.0%)Rejected-Finance PLOT NO 63 UDYOG VIHAR PH IV GURUGRAM 122015 GURGAON HARYANA 122001 | GURUGRAM | HARYANA | 122015 | ₹2+₹1 (100.0%) | 2 | Rejected-Finance Higher Rate |
Tender Value
Refer Docs
EMD Value
₹2 L
Closing Date
21 Aug 2021, 2:00 pmClosed
MD, NHM, Assam
Office of the NHM, Assam
supply essential kits for detection of Hepatitis virus
2021_NHM_22225_1
KitHepatitisvirus_170018
Open Tender
Medicines
Supply
60 days
MD, NHM
Please refer Tender documents.
2 documents required · 2 mandatory
₹2,000
State Health Society, Assam
₹2 L
MD, NHM, Assam
3 Sept 2022
23 Jul 2021
21 Aug 2021
23 Jul 2021
21 Aug 2021
16 Aug 2021
30 Jul 2021
Hepatitis A Virus The assay should detect IgM anti HAV antibodies. Anti-HAV IgM (ELISA) Assay should be based on the principle of "IgM capture/Indirect ELISA" Specification/Strength as per ANNEXURE-XIII-A.
Hepatitis B Virus, Hepatitis B Surface Antigen(ELISA) Microplate ELISA coated with monoclonal antibodies covering all subtypes and variants of HBsAg Specification/Strength as per ANNEXURE-XIII-A.
HBV & HCV-RTPCR kit Specification/Strength as per ANNEXURE-XIII-A
Hepatitis B core (HBc) IgM Antibody (ELISA) The assay should detect IgM antibodies to Hepatitis B core antigen Assay should be based on the principle of "IgM capture/Indirect ELISA" Specification/Strength as per ANNEXURE-XIII-A
Anti-HAV IgM (Rapid Test) Assay should be based on the principle of "IgM anti HAV antibodies. Specification/Strength as per ANNEXURE-XIII-A
HBsAg (Rapid Test) Should be coated with monoclonal antibodies covering all subtypes and variants of HBsAg. The assay should detect to detect surface antigen to Hepatitis B virus. Specification/Strength as per ANNEXURE-XIII-A
Hepatitis C Virus Anti-HCV Antibody Kits (ELISA) Microplate ELISA coated with recombinant/synthetic peptide antigens for core, NS3, NS4 and NSS. The assay should detect total anti HCV antibodies. Specification/Strength as per ANNEXURE-XIII-A
Anti-HCV Antibody (Rapid Test) The assay should detect total anti HCV antibodies Should utilize recombinant and/or synthetic peptide antigens for core, NS3, NS4 and NSS. Specification/Strength as per ANNEXURE-XIII-A
Anti-HEV IgM (Rapid Test) The assay should detect IgM anti HEV antibodies Specification/Strength as per ANNEXURE-XIII-A
Hepatitis E Virus Anti HEV IgM Antibody (ELISA) The assay should detect IgM anti HEV antibodies. Assay should be based on the principle of "IgM capture/ indirect ELISA" Specification/Strength as per ANNEXURE-XIII-A
Avantor Performance Materials India Limited
Meril Diagnostic Pvt. Ltd.
Transasia Bio Medicals Ltd
Athenese-Dx Private Limited
Biogenix Inc. Pvt. Ltd.
stage.html
html • 0.06 MB
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .